Company facts
- Headquarters
- South San Francisco, California
- Most recent report
- 10-Q, filed Aug 12, 2026
- Filings on record
- 623 filings
- On EDGAR
- CIK 1382101
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 33
News 8 of 92
Prospectuses and Registrations 8 of 29
- 424B3 Prospectus supplement for an offering Apr 1, 2026
- S-3 Shelf registration statement Mar 23, 2026
- S-8 Registration statement for an employee plan Mar 23, 2026
- 424B5 Prospectus supplement for an offering Feb 10, 2026
- S-8 Registration statement for an employee plan May 30, 2025
- S-8 Registration statement for an employee plan Feb 27, 2025
- 424B5 Prospectus supplement for an offering Apr 2, 2024
- S-8 Registration statement for an employee plan Feb 27, 2024
Proxies 8 of 17
- DEFA14A Extra proxy material Apr 22, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2026
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- PRE 14A Preliminary proxy statement Apr 14, 2025
- DEFA14A Extra proxy material May 17, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 26, 2024
Ownership 8 of 409
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 30, 2026
- 4 Insider reported a trade Jun 9, 2026
- 4 Insider reported a trade Jun 9, 2026
- 4 Insider reported a trade Jun 9, 2026
- 4 Insider reported a trade Jun 9, 2026
- 4 Insider reported a trade Jun 9, 2026
Other 8 of 43
- ARS Annual report sent to shareholders Apr 22, 2026
- EFFECT Notice that a registration became effective Apr 1, 2026
- CORRESP Reply to SEC staff Mar 30, 2026
- UPLOAD Comment letter from SEC staff Mar 27, 2026
- ARS Annual report sent to shareholders Apr 25, 2025
- ARS Annual report sent to shareholders Apr 26, 2024
- EFFECT Notice that a registration became effective Nov 21, 2023
- CORRESP Reply to SEC staff Nov 17, 2023
Everything here comes from Sutro Biopharma, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.